166 related articles for article (PubMed ID: 1399692)
1. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
Lerthirunwong C; Cheng KT; Hladik WB
Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
[TBL] [Abstract][Full Text] [Related]
2. Preparation and storage of single-dose portions of exametazime: effects on radiochemical purity after labeling.
Cheng KT; Spicer KM; Deshpande RV
Am J Hosp Pharm; 1992 Aug; 49(8):1950-4. PubMed ID: 1332470
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
[TBL] [Abstract][Full Text] [Related]
4. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
Vilcek S; Kalincák M; Machán V
Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
[TBL] [Abstract][Full Text] [Related]
6. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose.
Bogsrud TV; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Aug; 20(8):761-7. PubMed ID: 10451885
[TBL] [Abstract][Full Text] [Related]
8. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
9. Failure of quality control to detect errors in the preparation of technetium-99m disofenin (DISIDA).
Lecklitner ML; Benedetto AR; Straw JD
Clin Nucl Med; 1985 Jul; 10(7):468-74. PubMed ID: 4028598
[TBL] [Abstract][Full Text] [Related]
10. Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate.
Hoch DJ; Pinkerton TC
Int J Rad Appl Instrum A; 1986; 37(7):593-8. PubMed ID: 3021661
[TBL] [Abstract][Full Text] [Related]
11. The effect on radiochemical purity of modifications to the method of preparation and dilution of 99mTc-sestamibi.
Cooper M; Dustan K; Rotureau L
Nucl Med Commun; 2006 May; 27(5):455-60. PubMed ID: 16609357
[TBL] [Abstract][Full Text] [Related]
12. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
13. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
Millar AM
Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
[TBL] [Abstract][Full Text] [Related]
15. An investigation of factors that might influence the radiochemical purity and stability of 99mTc-MAG3.
Millar AM; O'Brien LM
Eur J Nucl Med; 1990; 16(8-10):615-9. PubMed ID: 2143474
[TBL] [Abstract][Full Text] [Related]
16. Radical scavengers and the stability of 99mTc-radiopharmaceuticals.
Berger R
Int J Appl Radiat Isot; 1982 Dec; 33(12):1341-4. PubMed ID: 7169269
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of fractionating MAG3 cold kit for cost reduction.
Thorson LM; Hung JC; Hollar BS
Nucl Med Commun; 1992 Nov; 13(11):832-7. PubMed ID: 1470426
[TBL] [Abstract][Full Text] [Related]
18. An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1.
Choi SR; Kung MP; Plössl K; Meegalla S; Kung HF
Nucl Med Biol; 1999 May; 26(4):461-6. PubMed ID: 10382851
[TBL] [Abstract][Full Text] [Related]
19. Quality of radiochemical purity in multiple samples of various fractionated cold kits: Testing a cost & time effective technique.
Negi M; Dhingra M; Dhingra VK
Hell J Nucl Med; 2019; 22(3):200-205. PubMed ID: 31587030
[TBL] [Abstract][Full Text] [Related]
20. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
Najafi A; Hutchison N
J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
